Gene · 7075
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation. | Int J Mol Sci | 2023 | 37298296 | PubTator, text mining | PubMed |
| A Three-Dimensional Vibration Theory for Ultralight Cellular Sandwich Plates Subjected to Linearly Varying In-Plane Distributed Loads. | Materials (Basel) | 2023 | 37297220 | PubTator, text mining | PubMed |
| Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy. | Front Bioeng Biotechnol | 2023 | 37288355 | PubTator, text mining | PubMed |
| Inflammatory-associated proteomic predictors of cognitive outcome in subjects with ELVO treated by mechanical thrombectomy. | BMC Neurol | 2023 | 37280551 | PubTator, text mining | PubMed |
| Role of UDP-glucose ceramide glucosyltransferase in venous malformation. | Front Cell Dev Biol | 2023 | 37274734 | PubTator, text mining | PubMed |
| Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. | Front Neurol | 2023 | 37273690 | PubTator, text mining | PubMed |
| Differences in the Cell Type-Specific Toxicity of Diamond Nanoparticles to Endothelial Cells Depending on the Exposure of the Cells to Nanoparticles. | Int J Nanomedicine | 2023 | 37273285 | PubTator, text mining | PubMed |
| Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration. | Pharmaceutics | 2023 | 37242655 | PubTator, text mining | PubMed |
| Novel Metal Nanomaterials to Promote Angiogenesis in Tissue Regeneration. | Eng Regen | 2023 | 37234753 | PubTator, text mining | PubMed |
| The use of innovative targeted angiogenic therapies for ischemic diabetic foot ulcer repair: From nanomedicine and microRNAs toward hyperbaric oxygen therapy. | Porto Biomed J | 2023 | 37213252 | PubTator, text mining | PubMed |
| Angiopoietin-like 2 Protein and Hidradenitis Suppurativa: A New Biomarker for Disease Severity. | Biomedicines | 2023 | 37189824 | PubTator, text mining | PubMed |
| An overview of the molecular and clinical significance of the angiopoietin system in leukemia. | J Recept Signal Transduct Res | 2023 | 37186553 | PubTator, text mining | PubMed |
| The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease. | Front Cardiovasc Med | 2023 | 37180779 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| More friends on SNS, more materialism? The moderating roles of self-esteem and social comparison orientation. | PLoS One | 2023 | 37163545 | PubTator, text mining | PubMed |
| Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies. | Front Med (Lausanne) | 2023 | 37153080 | PubTator, text mining | PubMed |
| Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases. | J Cardiovasc Dev Dis | 2023 | 37103045 | PubTator, text mining | PubMed |
| Svep1 is a binding ligand of Tie1 and affects specific aspects of facial lymphatic development in a Vegfc-independent manner. | Elife | 2023 | 37097004 | Swiss-Prot, curated | PubMed |
| Possible biallelic inheritance in TIE1 in a family with congenital lymphedema, intestinal lymphangiectasia and cutis aplasia. | Clin Genet | 2023 | 37096293 | PubTator, text mining | PubMed |
| Angiopoietin-2-Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma. | Cancer Res | 2023 | 37093870 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7075/papers?page=11